CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Aurinia Pharmaceuticals Inc.

For profitContributed to NMEWebsite ↗

Also known as: AURINIA | Aurinia Pharmaceuticals Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jan 1, 2012

First marketed drug

Jan 22, 2021

First NDA

Jan 22, 2021

Last known activity

Dec 31, 2023

Timeline

2010s

  1. Jan 1, 2012

    Aurinia Pharmaceuticals Inc.— Founded

  2. Feb 5, 2013

    Isotechnika— Acquired

2020s

  1. Jan 22, 2021

    voclosporin— Marketing Organization

  2. Jan 22, 2021

    voclosporin— NDA Organization

  3. Jan 22, 2021

    voclosporin— NDA Secondary Org

Drugs by trial phase (4 distinct, 17 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (18)

Details

Founded
Victoria, CA Jan 1, 2012
First NDA
Jan 22, 2021
Last known activity
Dec 31, 2023

Designations held

  • Fast track
  • Priority review